Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 143

1.

Antimicrobial anaphylaxis: the changing face of severe antimicrobial allergy.

Hall V, Wong M, Munsif M, Stevenson BR, Elliott K, Lucas M, Baird AJ, Athan E, Young M, Pickles R, Cheng AC, Stewardson AJ, Aung AK, Trubiano JA.

J Antimicrob Chemother. 2019 Oct 21. pii: dkz422. doi: 10.1093/jac/dkz422. [Epub ahead of print]

PMID:
31637446
2.

An Emerging Human Parechovirus Type 5 Causing Sepsis-Like Illness in Infants in Australia.

Chamings A, Liew KC, Reid E, Athan E, Raditsis A, Vuillermin P, Yoga Y, Caly L, Druce J, Alexandersen S.

Viruses. 2019 Oct 3;11(10). pii: E913. doi: 10.3390/v11100913.

3.

Central venous catheter associated blood stream infections (CVC-BSIs) in the non-intensive care settings: Epidemiology, microbiology and outcomes.

Aminzadeh Z, Simpson P, Athan E.

Infect Dis Health. 2019 Nov;24(4):222-228. doi: 10.1016/j.idh.2019.07.003. Epub 2019 Aug 7.

PMID:
31401054
4.

Simethicone use during gastrointestinal endoscopy: Position statement of the Gastroenterological Society of Australia.

Devereaux BM, Taylor ACF, Athan E, Wallis DJ, Brown RR, Greig SM, Bailey FK, Vickery K, Wardle E, Jones DM.

J Gastroenterol Hepatol. 2019 Jun 26. doi: 10.1111/jgh.14757. [Epub ahead of print] Review.

PMID:
31242327
5.

Six versus eight weeks of antibiotics for small Mycobacteriumulcerans lesions in Australian Patients.

O'Brien DP, Friedman ND, Cowan R, Walton A, Athan E.

Clin Infect Dis. 2019 Jun 20. pii: ciz532. doi: 10.1093/cid/ciz532. [Epub ahead of print]

PMID:
31231766
6.

Enterococcal bacteraemia "Silent but deadly": a population-based cohort study.

Cabiltes I, Coghill S, Bowe SJ, Athan E.

Intern Med J. 2019 Jun 10. doi: 10.1111/imj.14396. [Epub ahead of print]

PMID:
31180166
7.

Corrigendum to "association between the timing of surgery for complicated, left-sided infective endocarditis and survival", American HeartJournal 2019, volume 210, April 2019, pages 108-116.

Wang A, Chu VH, Athan E, Delahaye F, Freiberger T, Lamas C, Miro JM, Strahilevitz J, Tribouilloy C, Durante-Mangoni E, Pericas JM, Fernández-Hidalgo N, Nacinovich F, Barsic B, Giannitsioti E, Hurley JP, Hannan MM, Park LP; ICE-PLUS Investigators.

Am Heart J. 2019 Jun;212:165. doi: 10.1016/j.ahj.2019.03.006. Epub 2019 Apr 16. No abstract available.

PMID:
31003633
8.

The association between vegetation size and surgical treatment on 6-month mortality in left-sided infective endocarditis.

Fosbøl EL, Park LP, Chu VH, Athan E, Delahaye F, Freiberger T, Lamas C, Miro JM, Strahilevitz J, Tribouilloy C, Durante-Mangoni E, Pericas JM, Fernández-Hidalgo N, Nacinovich F, Rizk H, Barsic B, Giannitsioti E, Hurley JP, Hannan MM, Wang A; ICE-PLUS Investigators.

Eur Heart J. 2019 Jul 14;40(27):2243-2251. doi: 10.1093/eurheartj/ehz204.

PMID:
30977784
9.

Faecal microbiota transplants for depression - Who gives a crapsule?

Green J, Castle D, Berk M, Hair C, Loughman A, Cryan J, Nierenberg A, Athan E, Jacka F.

Aust N Z J Psychiatry. 2019 Aug;53(8):732-734. doi: 10.1177/0004867419839776. Epub 2019 Apr 8. No abstract available.

PMID:
30957511
10.

Association between the timing of surgery for complicated, left-sided infective endocarditis and survival.

Wang A, Chu VH, Athan E, Delahaye F, Freiberger T, Lamas C, Miro JM, Strahilevitz J, Tribouilloy C, Durante-Mangoni E, Pericas JM, Fernández-Hidalgo N, Nacinovich F, Barsic B, Giannitsioti E, Hurley JP, Hannan MM, Park LP; ICE-PLUS Investigators.

Am Heart J. 2019 Apr;210:108-116. doi: 10.1016/j.ahj.2019.01.004. Epub 2019 Jan 17. Erratum in: Am Heart J. 2019 Jun;212:165.

PMID:
30802708
11.

Spontaneous healing of Mycobacterium ulcerans disease in Australian patients.

O'Brien DP, Murrie A, Meggyesy P, Priestley J, Rajcoomar A, Athan E.

PLoS Negl Trop Dis. 2019 Feb 19;13(2):e0007178. doi: 10.1371/journal.pntd.0007178. eCollection 2019 Feb.

12.

Silent but deadly: patients with enterococcal bacteraemia should be assessed for colorectal neoplasia.

Athan E, Cabiltes I, Coghill S, Bowe SJ.

Med J Aust. 2019 Feb;210(2):86. doi: 10.5694/mja2.12027. Epub 2018 Nov 7. No abstract available.

PMID:
30712310
13.

Fosfomycin: what was old is new again.

Avent ML, Rogers BA, Cheng AC, Athan E, Francis JR, Roberts MJ, Paterson DL, Harris PNA.

Intern Med J. 2018 Dec;48(12):1425-1429. doi: 10.1111/imj.14122. No abstract available.

PMID:
30517987
14.

Australian infection control in endoscopy consensus statements on carbapenemase-producing Enterobacteriaceae.

Devereaux BM, Athan E, Brown RR, Greig SM, Jones DM, Bailey FK, Wallis DJ, Singh R.

J Gastroenterol Hepatol. 2019 Apr;34(4):650-658. doi: 10.1111/jgh.14511. Epub 2018 Nov 21.

PMID:
30345549
15.

Kidney Health Australia - Caring for Australasians with Renal Impairment guideline recommendations for infection control for haemodialysis units.

Jardine M, Commons RJ, de Zoysa JR, Wong MG, Gilroy N, Green J, Henderson B, Stuart RL, Tunnicliffe DJ, van Eps C, Athan E.

Nephrology (Carlton). 2019 Sep;24(9):951-957. doi: 10.1111/nep.13511. Epub 2019 Apr 29.

PMID:
30328179
16.

The changing epidemiology worldwide of Mycobacterium ulcerans.

O'Brien DP, Jeanne I, Blasdell K, Avumegah M, Athan E.

Epidemiol Infect. 2018 Oct 8:1-8. doi: 10.1017/S0950268818002662. [Epub ahead of print]

17.

Mycobacterium ulcerans disease management in Australian patients: the re-emergence of surgery as an important treatment modality.

O'Brien DP, Callan P, Friedman ND, Athan E, Hughes A, McDonald A.

ANZ J Surg. 2019 Jun;89(6):653-658. doi: 10.1111/ans.14829. Epub 2018 Sep 21. Review.

PMID:
30239097
18.

Effect of Piperacillin-Tazobactam vs Meropenem on 30-Day Mortality for Patients With E coli or Klebsiella pneumoniae Bloodstream Infection and Ceftriaxone Resistance: A Randomized Clinical Trial.

Harris PNA, Tambyah PA, Lye DC, Mo Y, Lee TH, Yilmaz M, Alenazi TH, Arabi Y, Falcone M, Bassetti M, Righi E, Rogers BA, Kanj S, Bhally H, Iredell J, Mendelson M, Boyles TH, Looke D, Miyakis S, Walls G, Al Khamis M, Zikri A, Crowe A, Ingram P, Daneman N, Griffin P, Athan E, Lorenc P, Baker P, Roberts L, Beatson SA, Peleg AY, Harris-Brown T, Paterson DL; MERINO Trial Investigators and the Australasian Society for Infectious Disease Clinical Research Network (ASID-CRN).

JAMA. 2018 Sep 11;320(10):984-994. doi: 10.1001/jama.2018.12163. Erratum in: JAMA. 2019 Jun 18;321(23):2370.

19.

Low incidence of recurrent Buruli ulcers in treated Australian patients living in an endemic region.

Wynne JW, Stinear TP, Athan E, Michalski WP, O'Brien DP.

PLoS Negl Trop Dis. 2018 Aug 13;12(8):e0006724. doi: 10.1371/journal.pntd.0006724. eCollection 2018 Aug.

20.

Bilateral osteomyelitis and liver abscess caused by hypervirulent Klebsiella pneumoniae- a rare clinical manifestation (case report).

Sturm E, Tai A, Lin B, Kwong J, Athan E, Howden BP, Angliss RD, Asaid R, Pollard J.

BMC Infect Dis. 2018 Aug 7;18(1):380. doi: 10.1186/s12879-018-3277-4.

21.

Quality of Life Impact of an Adjuvanted Recombinant Zoster Vaccine in Adults Aged 50 Years and Older.

Curran D, Oostvogels L, Heineman T, Matthews S, McElhaney J, McNeil S, Diez-Domingo J, Lal H, Andrews C, Athan E, Berglund J, Campora L, de Looze F, Korhonen T, Leung E, Levin M, Volpi A, Johnson RW; ZOE-50/70 Study Group.

J Gerontol A Biol Sci Med Sci. 2019 Jul 12;74(8):1231-1238. doi: 10.1093/gerona/gly150.

22.

Health issues of refugees attending an infectious disease refugee health clinic in a regional Australian hospital

Masters PJ, Lanfranco PJ, Sneath E, Wade AJ, Huffam S, Pollard J, Standish J, McCloskey K, Athan E, O'Brien DP, Friedman ND.

Aust J Gen Pract. 2018 May;47(5):305-310. doi: 10.31128/AFP-10-17-4355.

23.

Scrub typhus diagnosis on acute specimens using serological and molecular assays - a 3-year prospective study.

Koralur M, Singh R, Varma M, Shenoy S, Acharya V, Kamath A, Stenos J, Athan E, Bairy I.

Diagn Microbiol Infect Dis. 2018 Jun;91(2):112-117. doi: 10.1016/j.diagmicrobio.2018.01.018. Epub 2018 Feb 24.

PMID:
29706479
24.

Aiming for elimination: Outcomes of a consultation pathway supporting regional general practitioners to prescribe direct-acting antiviral therapy for hepatitis C.

Wade AJ, McCormack A, Roder C, McDonald K, Davies M, Scott N, Wardrop M, Athan E, Hellard ME.

J Viral Hepat. 2018 Sep;25(9):1089-1098. doi: 10.1111/jvh.12910. Epub 2018 May 8.

PMID:
29660212
25.

Managing diabetic foot infections: a survey of Australasian infectious diseases clinicians.

Commons RJ, Raby E, Athan E, Bhally H, Chen S, Guy S, Ingram PR, Lai K, Lemoh C, Lim LL, Manning L, Miyakis S, O'Reilly M, Roberts A, Sehu M, Torda A, Vicaretti M, Lazzarini PA.

J Foot Ankle Res. 2018 Apr 10;11:13. doi: 10.1186/s13047-018-0256-3. eCollection 2018.

26.

Tackling the worsening epidemic of Buruli ulcer in Australia in an information void: time for an urgent scientific response.

O'Brien DP, Athan E, Blasdell K, De Barro P.

Med J Aust. 2018 Apr 16;208(7):287-289. No abstract available.

PMID:
29642808
27.

Wound healing: Natural history and risk factors for delay in Australian patients treated with antibiotics for Mycobacterium ulcerans disease.

O'Brien DP, Friedman ND, McDonald A, Callan P, Hughes A, Walton A, Athan E.

PLoS Negl Trop Dis. 2018 Mar 19;12(3):e0006357. doi: 10.1371/journal.pntd.0006357. eCollection 2018 Mar.

28.

Morbidity from in-hospital complications is greater than treatment failure in patients with Staphylococcus aureus bacteraemia.

Holmes NE, Robinson JO, van Hal SJ, Munckhof WJ, Athan E, Korman TM, Cheng AC, Turnidge JD, Johnson PDR, Howden BP; VANESSA study group, on behalf of the Australasian Society for Infectious Diseases (ASID) Clinical Research Network (CRN).

BMC Infect Dis. 2018 Mar 5;18(1):107. doi: 10.1186/s12879-018-3011-2.

29.

Severe Rhabdomyolysis Associated With RSV.

Bender J, Chew R, Lin BB, Athan E.

Open Forum Infect Dis. 2017 Dec 22;5(1):ofx273. doi: 10.1093/ofid/ofx273. eCollection 2018 Jan.

30.

Increased Severity and Spread of Mycobacterium ulcerans, Southeastern Australia.

Tai AYC, Athan E, Friedman ND, Hughes A, Walton A, O'Brien DP.

Emerg Infect Dis. 2018 Jan;24(1). doi: 10.3201/eid2401.171070. Epub 2018 Jan 17.

31.

The rise of methicillin resistant Staphylococcus aureus: now the dominant cause of skin and soft tissue infection in Central Australia.

Macmorran E, Harch S, Athan E, Lane S, Tong S, Crawford L, Krishnaswamy S, Hewagama S.

Epidemiol Infect. 2017 Oct;145(13):2817-2826. doi: 10.1017/S0950268817001716. Epub 2017 Aug 14.

PMID:
28803587
32.

High burden of complicated skin and soft tissue infections in the Indigenous population of Central Australia due to dominant Panton Valentine leucocidin clones ST93-MRSA and CC121-MSSA.

Harch SAJ, MacMorran E, Tong SYC, Holt DC, Wilson J, Athan E, Hewagama S.

BMC Infect Dis. 2017 Jun 7;17(1):405. doi: 10.1186/s12879-017-2460-3.

33.

Antibiotic complications during the treatment of Mycobacterium ulcerans disease in Australian patients.

O'Brien DP, Friedman D, Hughes A, Walton A, Athan E.

Intern Med J. 2017 Sep;47(9):1011-1019. doi: 10.1111/imj.13511.

PMID:
28585259
34.

The Current Epidemiology of Injecting Drug Use-Associated Infective Endocarditis in Victoria, Australia in the Midst of Increasing Crystal Methamphetamine Use.

Wright A, Otome O, Harvey C, Bowe S, Athan E.

Heart Lung Circ. 2018 Apr;27(4):484-488. doi: 10.1016/j.hlc.2017.03.166. Epub 2017 May 9.

PMID:
28533098
35.

Exposure Risk for Infection and Lack of Human-to-Human Transmission of Mycobacterium ulcerans Disease, Australia.

O'Brien DP, Wynne JW, Buultjens AH, Michalski WP, Stinear TP, Friedman ND, Hughes A, Athan E.

Emerg Infect Dis. 2017 May;23(5):837-840. doi: 10.3201/eid2305.160809.

36.

Efficacy of the Herpes Zoster Subunit Vaccine in Adults 70 Years of Age or Older.

Cunningham AL, Lal H, Kovac M, Chlibek R, Hwang SJ, Díez-Domingo J, Godeaux O, Levin MJ, McElhaney JE, Puig-Barberà J, Vanden Abeele C, Vesikari T, Watanabe D, Zahaf T, Ahonen A, Athan E, Barba-Gomez JF, Campora L, de Looze F, Downey HJ, Ghesquiere W, Gorfinkel I, Korhonen T, Leung E, McNeil SA, Oostvogels L, Rombo L, Smetana J, Weckx L, Yeo W, Heineman TC; ZOE-70 Study Group.

N Engl J Med. 2016 Sep 15;375(11):1019-32. doi: 10.1056/NEJMoa1603800.

37.

Identifying and integrating patient and caregiver perspectives for clinical practice guidelines on the screening and management of infectious microorganisms in hemodialysis units.

Miller HM, Tong A, Tunnicliffe DJ, Campbell D, Pinter J, Commons RJ, Athan E, Craig JC, Gilroy N, Green J, Henderson B, Howell M, Stuart RL, van Eps C, Wong MG, de Zoysa J, Jardine MJ.

Hemodial Int. 2017 Apr;21(2):213-223. doi: 10.1111/hdi.12457. Epub 2016 Jul 8.

PMID:
27389043
38.

Australasian Society of Infectious Diseases updated guidelines for the management of Clostridium difficile infection in adults and children in Australia and New Zealand.

Trubiano JA, Cheng AC, Korman TM, Roder C, Campbell A, May ML, Blyth CC, Ferguson JK, Blackmore TK, Riley TV, Athan E.

Intern Med J. 2016 Apr;46(4):479-93. doi: 10.1111/imj.13027.

PMID:
27062204
39.

Increasing Experience with Primary Oral Medical Therapy for Mycobacterium ulcerans Disease in an Australian Cohort.

Friedman ND, Athan E, Walton AL, O'Brien DP.

Antimicrob Agents Chemother. 2016 Apr 22;60(5):2692-5. doi: 10.1128/AAC.02853-15. Print 2016 May.

40.

Mucormycosis in Australia: contemporary epidemiology and outcomes.

Kennedy KJ, Daveson K, Slavin MA, van Hal SJ, Sorrell TC, Lee A, Marriott DJ, Chapman B, Halliday CL, Hajkowicz K, Athan E, Bak N, Cheong E, Heath CH, Morrissey CO, Kidd S, Beresford R, Blyth C, Korman TM, Robinson JO, Meyer W, Chen SC; Australia and New Zealand Mycoses Interest Group of the Australasian Society for Infectious Diseases.

Clin Microbiol Infect. 2016 Sep;22(9):775-781. doi: 10.1016/j.cmi.2016.01.005. Epub 2016 Jan 20.

41.

Mycobacterium ulcerans in the Elderly: More Severe Disease and Suboptimal Outcomes.

O'Brien DP, Friedman ND, Cowan R, Pollard J, McDonald A, Callan P, Hughes A, Athan E.

PLoS Negl Trop Dis. 2015 Dec 2;9(12):e0004253. doi: 10.1371/journal.pntd.0004253. eCollection 2015 Dec.

42.

One Health approach to controlling a Q fever outbreak on an Australian goat farm.

Bond KA, Vincent G, Wilks CR, Franklin L, Sutton B, Stenos J, Cowan R, Lim K, Athan E, Harris O, Macfarlane-Berry L, Segal Y, Firestone SM.

Epidemiol Infect. 2016 Apr;144(6):1129-41. doi: 10.1017/S0950268815002368. Epub 2015 Oct 23.

43.

Response to Letter Regarding Article, "Association Between Surgical Indications, Operative Risk, and Clinical Outcome in Infective Endocarditis: A Prospective Study From the International Collaboration on Endocarditis".

Chu VH, Park LP, Athan E, Delahaye F, Freiberger T, Lamas C, Miro JM, Mudrick DW, Strahilevitz J, Tribouilloy C, Durante-Mangoni E, Pericas JM, Fernández-Hidalgo N, Nacinovich F, Rizk H, Krajinovic V, Giannitsioti E, Hurley JP, Hannan MM, Wang A; ICE Investigators.

Circulation. 2015 Oct 6;132(14):e184-5. doi: 10.1161/CIRCULATIONAHA.115.016782. No abstract available.

PMID:
26438777
44.

Effectiveness of a care bundle to reduce central line-associated bloodstream infections.

Entesari-Tatafi D, Orford N, Athan E.

Med J Aust. 2015 Aug 3;203(3):138. No abstract available.

PMID:
26224183
45.

Clinical MRSA isolates from skin and soft tissue infections show increased in vitro production of phenol soluble modulins.

Berlon NR, Qi R, Sharma-Kuinkel BK, Joo HS, Park LP, George D, Thaden JT, Messina JA, Maskarinec SA, Mueller-Premru M, Athan E, Tattevin P, Pericas JM, Woods CW, Otto M, Fowler VG Jr.

J Infect. 2015 Oct;71(4):447-57. doi: 10.1016/j.jinf.2015.06.005. Epub 2015 Jun 14.

46.

Survey of infection control and antimicrobial stewardship practices in Australian residential aged-care facilities.

Stuart RL, Marshall C, Orr E, Bennett N, Athan E, Friedman D, Reilly M; Members of RACRIG (Residential Aged Care Research Interest Group).

Intern Med J. 2015 May;45(5):576-80. doi: 10.1111/imj.12740.

PMID:
25955463
47.

Effectiveness of a care bundle to reduce central line-associated bloodstream infections.

Entesari-Tatafi D, Orford N, Bailey MJ, Chonghaile MN, Lamb-Jenkins J, Athan E.

Med J Aust. 2015 Mar 16;202(5):247-50.

PMID:
25758694
48.

Sequence type 131 fimH30 and fimH41 subclones amongst Escherichia coli isolates in Australia and New Zealand.

Rogers BA, Ingram PR, Runnegar N, Pitman MC, Freeman JT, Athan E, Havers S, Sidjabat HE, Gunning E, De Almeida M, Styles K, Paterson DL; ASID CRN.

Int J Antimicrob Agents. 2015 Apr;45(4):351-8. doi: 10.1016/j.ijantimicag.2014.11.015. Epub 2015 Jan 13.

PMID:
25707371
49.

Invasive infections due to filamentous fungi other than Aspergillus: epidemiology and determinants of mortality.

Slavin M, van Hal S, Sorrell TC, Lee A, Marriott DJ, Daveson K, Kennedy K, Hajkowicz K, Halliday C, Athan E, Bak N, Cheong E, Heath CH, Orla Morrissey C, Kidd S, Beresford R, Blyth C, Korman TM, Owen Robinson J, Meyer W, Chen SC; Australia and New Zealand Mycoses Interest Group.

Clin Microbiol Infect. 2015 May;21(5):490.e1-10. doi: 10.1016/j.cmi.2014.12.021. Epub 2015 Jan 14.

50.

Mycobacterium ulcerans treatment--can antibiotic duration be reduced in selected patients?

Cowan R, Athan E, Friedman ND, Hughes AJ, McDonald A, Callan P, Fyfe J, O'Brien DP.

PLoS Negl Trop Dis. 2015 Feb 6;9(2):e0003503. doi: 10.1371/journal.pntd.0003503. eCollection 2015 Feb.

Supplemental Content

Support Center